REXULTI

Approval Id: f3c2f3c3a6f76459
Drug Approval Canada Name: REXULTI
Product Name: REXULTI
Status: Cancelled Post Market
Status Date: 2022-10-31
Original Market Date: 2019-06-08
Din: 02485923
Drug Class: Human
Dosage Form: Kit , Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.08.04
Atc Original: N05AX16 BREXPIPRAZOLE
Atc Name: n 05 ax 16
Aig Number: 0261230001
Company Name: OTSUKA PHARMACEUTICAL CO., LTD.
Company Address: 2-9 Kanda-Tsukasamachi, Chiyoda-Ku Tokyo, --, Japan, 101-8535
Company Detail Path: /organization/otsuka-pharmaceutical-co-ltd

BREXPIPRAZOLE

1 MG

BREXPIPRAZOLE

0.5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f3c2f3c3a6f76459

Type

Standard